Welcome to our dedicated page for Transdigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransDigm Group Incorporated (NYSE: TDG) files a variety of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its aerospace components business, capital structure and governance. This page compiles TransDigm’s SEC filings and pairs them with AI-powered summaries to help readers interpret the information more efficiently.
Investors can use this resource to locate annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically describe TransDigm’s business segments, risk factors, product categories and financial results. For this company, filings often discuss its role as a designer, producer and supplier of highly engineered aircraft components, its organization into segments such as power and control and airframes, and its use of acquisitions and financial leverage as part of its strategy, as reflected in the Polygon description and company disclosures.
Current reports on Form 8-K are particularly important for tracking material events at TransDigm. Recent 8-K filings describe acquisitions such as the Simmonds Precision Products business and a definitive agreement to acquire Stellant Systems, debt offerings and amendments to the company’s credit agreement, special cash dividends funded with new debt and changes in executive leadership and board composition. These documents provide timely details on transactions, financing terms and governance decisions.
This page also offers access to filings related to debt instruments and credit agreements, where TransDigm outlines terms for senior secured notes, senior subordinated notes and term loans, as well as any amendments that reprice or extend these facilities. Where available, insider transaction reports on Form 4 and proxy statements on Schedule 14A can shed light on executive and director share ownership and compensation structures.
Stock Titan’s platform enhances these filings with AI-generated highlights and explanations, helping users quickly identify key sections, understand complex capital structure language and see how new 8-K events connect to prior disclosures. Real-time updates from EDGAR ensure that new TransDigm filings appear promptly, while the AI layer reduces the time needed to parse lengthy documents and track the regulatory record for TDG.
An affiliated trust of the issuer for ticker TDG has filed a notice of proposed common stock sales under Rule 144. The filing states that 25,000 common shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of
The 25,000 shares were acquired on
An affiliate of TDG filed a notice to sell 290 common shares through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an indicated aggregate market value of
Over the prior three months, the same account executed additional Rule 10b5‑1 sales of TDG common stock: 290 shares on 12/01/2025 for gross proceeds of
TransDigm Group Incorporated has signed a definitive agreement to acquire Stellant Systems, Inc. for approximately
Stellant is expected to generate about
TransDigm Group Inc.’s Co-Chief Operating Officer reported an option exercise and related stock sales. On 12/15/2025, he exercised 3,900 stock options at an exercise price of $284.97 per share and received the same number of TransDigm common shares. The filing then shows multiple open-market sales of TransDigm common stock that day in small blocks at weighted-average prices within ranges from about $1,282.12 to $1,311.40. After these transactions, he directly beneficially owned 3,600 shares of common stock and held 39,200 stock options that remain outstanding.
TransDigm Group Inc. director reports option exercise and share sales. On 12/10/2025, the reporting person exercised a stock option for 4,700 shares of TransDigm common stock at an exercise price of $66.47 per share and acquired those shares. The same day, they sold a total of 4,700 shares in three open market transactions: 580 shares at a weighted average price of $1,289.3197, 4,046 shares at $1,290.2959, and 74 shares at $1,291.0322, leaving 5,625 shares held directly.
The option covered 4,700 shares of common stock, was exercisable beginning 09/30/2018, and was set to expire on 11/08/2027. After these transactions, the reporting person also continues to hold significant indirect ownership, including 366,141 shares through Stockbridge Fund, L.P., 68,139 shares through Stockbridge Partners LLC, and 60,246 shares through family trusts.
An affiliate of TDG has filed a notice to sell common stock. The filing covers a proposed sale of 4,700 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, with an aggregate market value of $6,063,878.90. The issuer had 56,318,584 shares outstanding at the time referenced. The shares to be sold were acquired on 12/10/2025 by exercising stock options under a registered plan, with the purchase price paid in cash on the same date. The notice also confirms that the seller represents not knowing any undisclosed material adverse information about the issuer’s current or prospective operations.
TransDigm Group director Robert J. Small reported sales of the company’s common stock in a Form 4 filing. On 12/09/2025, entities associated with him sold 75,673 and 15,280 shares of TransDigm common stock at
After these transactions, 366,141 shares are held indirectly through Stockbridge Fund, L.P., 68,139 shares through Stockbridge Partners LLC, and 60,246 shares through certain family trusts, with an additional 5,625 shares held directly. The filing states that Small may be deemed to share voting and dispositive power over these holdings but disclaims beneficial ownership beyond any pecuniary interest.
A shareholder of TDG has given notice of intent to sell 100,000 shares of common stock through Goldman, Sachs & Co., with an aggregate market value of $134,717,000. The notice states that there are 56,318,584 shares of this common stock outstanding and that the proposed sale is to be made on the NYSE on or about 12/09/2025.
In addition, the disclosure shows that Stockbridge Partners LLC sold 5,000 shares of the same common stock in the past three months, on 09/12/2025, for gross proceeds of $6,384,923.50. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
TransDigm Group Inc. reported an insider stock transaction involving a company director. A stock option for 17,526 shares of common stock with an exercise price of
The trust then reported a series of open-market sales of TransDigm common stock on the same date at weighted average prices ranging from about
A shareholder has filed a notice of proposed sale of 17,526 shares of common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $23,438,045.58, compared with 56,318,584 shares of the same class reported as outstanding. The seller acquired these 17,526 shares on 12/04/2025 through a cash exercise of stock options on that date.
Over the past three months, the person for whose account the securities are to be sold, identified in multiple entries as The Fortuna Trust U/T/A DTD 06/01/2018, has already sold several blocks of common stock under a Rule 10b5-1 plan, including 7,191 shares on 11/18/2025 for $9,791,047.47 and 4,592 shares on 11/28/2025 for $6,248,486.61. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.